https://legion100trial.com/
LEGION-100 Clinical Trial | mCRPC Prostate Cancer | Syncromune
Aug 22, 2025 - LEGION-100 Clinical Trial of investigational therapy for individuals diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
clinical trialprostate cancerlegionmcrpc
https://syncromune.com/
Syncromune — Now Enrolling LEGION-100 Trial for mCRPC
Jun 17, 2026 - Syncromune® is developing SYNC-T®, a platform immunotherapy designed to synchronize the location of 3 key components needed to educate the immune system to...
now enrollinglegiontrialmcrpc
https://pubmed.ncbi.nlm.nih.gov/32654030/
Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with...
This study confirms the validity of the 3-PS score for mCRPC patients. This score is simple, noninvasive and affordable and can be easily used to select...